FacebookTwitterGoogle+RedditEmail

The Komen Con

by DOUGLAS A. BERG

Nancy Goodman Brinker, a pioneer of “cause marketing”, founded Susan G. Komen For the Cure in 1982, reportedly as the fulfillment of a deathbed promise made to her sister, a victim of breast cancer. In 1994, Brinker founded In Your Corner, Inc., a for-profit company that markets health products and information. In 1998, Brinker sold In Your Corner to AstraZeneca, the third largest pesticide manufacturer in the world, primarily through Syngenta, a giant global agribusiness company it owns jointly with Novartis.

AstraZeneca has had close ties to Brinker for many years. It gave $97,000 to Komen and its affiliates in the first 6 months of 2008 alone, and it has been a big presence at Komen’s Race for the Cure. AstraZeneca is also one of the largest contributors to Breast Cancer Awareness Month.

The problem here is that pesticides cause breast cancer.

AstraZeneca solves the problem by no longer advertising itself as a pesticide manufacturer.  It is a “life-sciences” company. Ta da! Problem solved! Well, they still manufacture more pesticides than ever (substances that congregate in the sexual glands of mammals causing cancers, birth defects, etc., etc.,) but “life sciences” sounds so reassuring, yes?

Susan G. Komen has created a lengthy list of risk factors for breast cancer.  Nowhere in this list can you find exposure to toxins, probably the greatest risk factor of all.

Hey Nancy! Didn’t your sister ask you to cure breast cancer? Was her dying wish, “Please forgive them for killing me, pay yourself half a million dollars a year – and oh by the way please protect those poor pesticide manufacturers. They know not what they do.”

It gets worse. You’ve heard the famous slogan “The best prevention is early detection.” Think about it: If you get breast cancer, you didn’t see the doctor soon enough. Your fault. Next case.

No wonder AstraZeneca gives handsomely. The focus of Komen and pharmaceutical research is entirely on screening and treatment, not on prevention. In other words, “the cure” focuses on the symptoms and ignores the cause. Less than 5% of the total research dollars in this country are spent determining and eliminating the causes of cancer — none of that money, you can bet, spent by “life sciences” companies.

You have to hand it to AstraZeneca. Not only do they recognize and reward good propaganda when they see it, they also recognize a great market opportunity. Since the 90’s, AstraZeneca has bought up cancer treatment centers until it owns one of the country’s largest chains. With $13 billion in profits in 2011, it makes billions on oncology drugs, and it makes billions on pesticides and herbicides.

In business parlance, this is “vertical integration.” AstraZeneca causes cancer, they give money to charities that ignore the causes of cancer, and they “cure” us with their toxic drugs. An enviable business model–the worse the product, the more money they make.

And AstraZeneca isn’t the only culprit in this unholy alliance. General Electric is also a large contributor to Susan G. Komen. Mammograms have come under heavy criticism in recent years for needlessly exposing patients to radiation, and for yielding numerous false positives which often result in unnecessary surgeries. Unlike many doctors and charities, Komen continues to recommend annual mammograms. GE, not so coincidentally, is a huge manufacturer of mammogram equipment. Europe has a only fraction of the breast surgeries that occur in the U.S., and yet they have nearly identical rates of cancer deaths.

It is hard not to think of Komen as a pure propaganda ploy, and a great tool for supplying qualified prospects to the cancer industry. Is it any surprise that Nancy Brinker was a bundler of campaign contributions for George W. Bush and also a Bush Pioneer, a title that required making contributions of at least $100,000 to his Presidential Campaign? Is it surprising that the staff of Komen is stuffed full of right-wing extremists? Anyone surprised by Komen’s decision to drop Planned Parenthood?

If you are surprised, you’ve bought Susan G. Komen’s purported mission of “curing” breast cancer, rather than understanding the real mission of the cancer-industry and its supporters in the “life science” of killing insects with chemicals that also kill humans. Putting the spotlight upon this unholy alliance is making some very rich, very immoral people very nervous.

Expect a rash of corporate name changes and massive increases in public relations budgets if the attention lasts much longer. What one should not expect is any change in business practices.

Douglas A. Berg is a computer scientist and children’s book writer in Mesa, Arizona. He contributed this article to ThisCantBeHappening!, the new independent Project Censored Award-winning online alternative newspaper, which is available at www.thiscantbehappening.net

 

 

 

 

 

 

 

 

 

 

More articles by:

CounterPunch Magazine

minimag-edit

bernie-the-sandernistas-cover-344x550

zen economics

March 27, 2017
Robert Hunziker
A Record-Setting Climate Going Bonkers
Frank Stricker
Why $15 an Hour Should be the Absolute Minimum Minimum Wage
Melvin Goodman
The Disappearance of Bipartisanship on the Intelligence Committees
Patrick Cockburn
ISIS’s Losses in Syria and Iraq Will Make It Difficult to Recruit
Russell Mokhiber
Single-Payer Bernie Morphs Into Public Option Dean
Gregory Barrett
Can Democracy Save Us?
Dave Lindorff
Budget Goes Military
John Heid
Disappeared on the Border: “Chase and Scatter” — to Death
Mark Weisbrot
The Troubling Financial Activities of an Ecuadorian Presidential Candidate
Robert Fisk
As ISIS’s Caliphate Shrinks, Syrian Anger Grows
Michael J. Sainato
Democratic Party Continues Shunning Popular Sanders Surrogates
Paul Bentley
Nazi Heritage: the Strange Saga of Chrystia Freeland’s Ukrainian Grandfather
Christopher Ketcham
Buddhism in the Storm
Thomas Barker
Platitudes in the Wake of London’s Terror Attack
Mike Hastie
Insane Truths: a Vietnam Vet on “Apocalypse Now, Redux”
Binoy Kampmark
Cyclone Watch in Australia
Weekend Edition
March 24, 2017
Friday - Sunday
Michael Hudson
Trump is Obama’s Legacy: Will this Break up the Democratic Party?
Eric Draitser
Donald Trump and the Triumph of White Identity Politics
Jeffrey St. Clair
Roaming Charges: Nothing Was Delivered
Andrew Levine
Ryan’s Choice
Joshua Frank
Global Coal in Freefall, Tar Sands Development Drying Up (Bad News for Keystone XL)
Anthony DiMaggio
Ditching the “Deep State”: The Rise of a New Conspiracy Theory in American Politics
Rob Urie
Boris and Natasha Visit Fantasy Island
John Wight
London and the Dreary Ritual of Terrorist Attacks
Paul Buhle
The CIA and the Intellectuals…Again
David Rosen
Why Did Trump Target Transgender Youth?
Vijay Prashad
Inventing Enemies
Ben Debney
Outrage From the Imperial Playbook
M. Shadee Malaklou
An Open Letter to Duke University’s Class of 2007, About Your Open Letter to Stephen Miller
Michael J. Sainato
Bernie Sanders’ Economic Advisor Shreds Trumponomics
Lawrence Davidson
Moral Failure at the UN
Pete Dolack
World Bank Declares Itself Above the Law
Nicola Perugini - Neve Gordon
Israel’s Human Rights Spies
Patrick Cockburn
From Paris to London: Another City, Another Attack
Ralph Nader
Reason and Justice Address Realities
Ramzy Baroud
‘Decolonizing the Mind’: Using Hollywood Celebrities to Validate Islam
Colin Todhunter
Monsanto in India: The Sacred and the Profane
Louisa Willcox
Grizzlies Under the Endangered Species Act: How Have They Fared?
Norman Pollack
Militarization of American Fascism: Trump the Usurper
Pepe Escobar
North Korea: The Real Serious Options on the Table
Brian Cloughley
“These Things Are Done”: Eavesdropping on Trump
Sheldon Richman
You Can’t Blame Trump’s Military Budget on NATO
Carol Wolman
Trump vs the People: a Psychiatrist’s Analysis
Stanley L. Cohen
The White House . . . Denial and Cover-ups
Kollibri terre Sonnenblume
Marines to Kill Desert Tortoises
FacebookTwitterGoogle+RedditEmail